ASXChange of Director's Interest Notice x 4
director_dealing announcement
Cleo Diagnostics (COV) News
Latest articles and price-sensitive announcements with AI sentiment classification.
Google NewsCleo Diagnostics (ASX:COV) Shares Fall: Is the Pullback Putting the Cancer-Diagnostics Stock on the Watchlist? - Kalkine
Cleo Diagnostics (ASX:COV) Shares Fall: Is the Pullback Putting the Cancer-Diagnostics Stock on the Watchlist? Kalkine
CLEO Diagnostics (ASX:COV) Slips as ASX Biotech Volatility Stays in Focus - Kalkine
CLEO Diagnostics (ASX:COV) Slips as ASX Biotech Volatility Stays in Focus Kalkine
Why Has Cleo Diagnostics (ASX:COV) Gained Nearly 27% Over the Past Year? - Kalkine
Why Has Cleo Diagnostics (ASX:COV) Gained Nearly 27% Over the Past Year? Kalkine
CLEO Diagnostics (ASX:COV) Is Under Pressure. Here’s a Possible Explanation - Kalkine
CLEO Diagnostics (ASX:COV) Is Under Pressure. Here’s a Possible Explanation Kalkine
CLEO Commences Kit Manufacturing Ahead of FDA Submission
other announcement
Sample Collection Completion for Pivotal US Clinical Trial
other announcement
CLEO Optimises Biomarker Panel Ahead of FDA Submission
other announcement
CLEO Confirms Next-Gen Platform for Ovarian Cancer Test
other announcement
Notification regarding unquoted securities - COV
other announcement
Cleo Strengthens Cash Position with $1.7m R&D Tax Refund
other announcement
CLEO Appoints First Key Opinion Leader to Support US Market
other announcement
COV Commences Health Economic Study-Support US Market Entry
other announcement
Restricted securities to be released from escrow
other announcement
CLEO Strengthens FDA Submission - Access to US Biobank
other announcement
CLEO to Fast Track Development of Ovarian Cancer Test
other announcement
Notification regarding unquoted securities - COV
other announcement
CLEO Receives A$845k Research and Development Tax Incentive
other announcement